Evidence map›Paper›PMID 34360764›Full record

ArticleInternational journal of molecular sciences2021

Structure-Activity Relationships of the Imidazolium Compounds as Antibacterials of

Łukasz Pałkowski, Maciej Karolak, Jerzy Błaszczyński, Jerzy Krysiński, Roman Słowiński

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Łukasz PałkowskiDepartment of Pharmaceutical Technology, Faculty of Pharmacy, Nicolaus Copernicus University, Jurasza 2, 85-094 Bydgoszcz, Poland.ORCID 0000-0002-8219-6339
Maciej KarolakDepartment of Pharmaceutical Technology, Faculty of Pharmacy, Nicolaus Copernicus University, Jurasza 2, 85-094 Bydgoszcz, Poland.ORCID 0000-0001-9006-0549
Jerzy BłaszczyńskiInstitute of Computing Science, Poznań University of Technology, Piotrowo 2, 60-965 Poznań, Poland.
Jerzy KrysińskiDepartment of Pharmaceutical Technology, Faculty of Pharmacy, Nicolaus Copernicus University, Jurasza 2, 85-094 Bydgoszcz, Poland.
Roman SłowińskiInstitute of Computing Science, Poznań University of Technology, Piotrowo 2, 60-965 Poznań, Poland.

Funding

Polish Ministry of Education and Science 0311/SBAD/0709Uniwersytet Mikolaja Kopernika w Toruniu 44-IDUB 2020-1 NZ PAŁKOWSKIUniwersytet Mikolaja Kopernika w Toruniu WF527
6 · The paper itself

Abstract

This paper presents the results of structure-activity relationship (SAR) studies of 140 3,3'-(α,ω-dioxaalkan)bis(1-alkylimidazolium) chlorides. In the SAR analysis, the dominance-based rough set approach (DRSA) was used. For analyzed compounds, minimum inhibitory concentration (MIC) against strains of

Indexed as

Anti-Bacterial AgentsImidazolesPseudomonas aeruginosaStaphylococcus aureusStructure-Activity RelationshipAnti-Bacterial AgentsImidazolesantimicrobial activitydominance-based rough set approach (DRSA)gemini-imidazolium chloridesmolecular descriptorsSAR

Identifiers

PMID34360764
PMCPMC8347611

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.